As coronavirus hospitalizations rise, U.S. still doesn't have the test and trace tools in place, former FDA chief says

Deutschland Nachrichten Nachrichten

Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 CNBC
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 72%

“I don’t think we have everything we need in place.” Dr. Scott Gottlieb says the U.S. has not yet put the necessary infrastructure in place to combat the coronavirus outbreak.

Covid-19 hospitalizations are on the rise in a number of states, Gottlieb told CNBC. Hospitalizations are a "lagging indicator" since it takes several weeks for someone to become sick enough to be admitted. But health officials say they are more telling than confirmed infections, which depend on the availability of testing. He said Tennessee, Arizona, Texas, Georgia, North Carolina, Minnesota, Wisconsin and Ohio have all seen hospitalizations rise.

The government should be making efforts to test "medically and socially disadvantaged people" who are more likely to contract Covid-19 but still don't have access to testing, Gottlieb said. He added that state and local officials should be rolling out "very aggressive tracking and tracing" strategies.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

CNBC /  🏆 12. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

FDA struggles to remain independent amid race for virus cureFDA struggles to remain independent amid race for virus cureThe unprecedented effort by the White House to intercede at the FDA is raising alarms among health experts inside and outside the administration
Weiterlesen »

Antidepressant Zoloft and generic version in short supply, FDA saysAntidepressant Zoloft and generic version in short supply, FDA saysA spike in demand for anxiety and depression drugs has led to shortages of some forms of the commonly used antidepressant Zoloft and its generic, sertraline.
Weiterlesen »

Antidepressant Zoloft and generic version in short supply, FDA saysAntidepressant Zoloft and generic version in short supply, FDA saysThe shortage follows a sharp increase in reports of depression and anxiety in the U.S.
Weiterlesen »

Hype and science collide as FDA tries to rein in 'wild West' of COVID-19 blood testsHype and science collide as FDA tries to rein in 'wild West' of COVID-19 blood testsThe FDA is trying to rein in the chaos it created by allowing companies to flood the market with COVID-19 antibody tests of questionable accuracy.
Weiterlesen »

As coronavirus hospitalizations rise, U.S. still doesn't have the necessary tools in place, former FDA chief saysAs coronavirus hospitalizations rise, U.S. still doesn't have the necessary tools in place, former FDA chief saysThe government should be making efforts to test 'medically and socially disadvantaged people' who are more likely to contract Covid-19, but still don't have access to testing, Dr. Scott Gottlieb said.
Weiterlesen »



Render Time: 2025-03-25 02:34:43